TY - JOUR
T1 - Sarcoidosis and common variable immunodeficiency
T2 - Report of 8 cases and review of the literature
AU - Fasano, Mary Beth
AU - Sullivan, Kathleen E.
AU - Sarpong, Sampson B.
AU - Wood, Robert A.
AU - Jones, Stacie M.
AU - Johns, Carol J.
AU - Lederman, Howard M.
AU - Bykowsky, Michael J.
AU - Greene, Jeffrey M.
AU - Winkelstein, Jerry A.
PY - 1996/9
Y1 - 1996/9
N2 - The true incidence of sarcoidosis in common variable immunodeficiency (CVID) is unknown. We report here 8 cases of sarcoidosis among 80 patients with CVID followed in our clinics, along with 22 well-documented cases reported in the literature. Sarcoidosis, therefore, represents an important entity to consider among patients with CVID who exhibit clinical, radiographic, laboratory, and biopsy findings compatible with sarcoidosis. Conversely, the diagnosis of CVID should be considered in patients with sarcoidosis who do not exhibit the characteristic hypergammaglobulinemia and who have a history of recurrent infections. Although many features of sarcoidosis are similar in patients with CVID to those in patients with sarcoidosis alone, there are many important differences. Patients with CVID in whom sarcoidosis develops present with hypogammaglobulinemia rather than hypergammaglobulinemia and have a higher prevalence of recurrent infections, thrombocytopenia, and splenic involvement. Steroids, in most cases, appeared helpful in reducing adenopathy and splenomegaly, improving uveitis, lowering serum alkaline phosphatase, and reversing hematologic abnormalities. The underlying pathophysiology responsible for the association of these 2 disorders in the same patient remains obscure. However, as more patients are identified, it may be possible to gain a better understanding of the immunologic defect responsible for the dual presentation of these 2 relatively uncommon diseases.
AB - The true incidence of sarcoidosis in common variable immunodeficiency (CVID) is unknown. We report here 8 cases of sarcoidosis among 80 patients with CVID followed in our clinics, along with 22 well-documented cases reported in the literature. Sarcoidosis, therefore, represents an important entity to consider among patients with CVID who exhibit clinical, radiographic, laboratory, and biopsy findings compatible with sarcoidosis. Conversely, the diagnosis of CVID should be considered in patients with sarcoidosis who do not exhibit the characteristic hypergammaglobulinemia and who have a history of recurrent infections. Although many features of sarcoidosis are similar in patients with CVID to those in patients with sarcoidosis alone, there are many important differences. Patients with CVID in whom sarcoidosis develops present with hypogammaglobulinemia rather than hypergammaglobulinemia and have a higher prevalence of recurrent infections, thrombocytopenia, and splenic involvement. Steroids, in most cases, appeared helpful in reducing adenopathy and splenomegaly, improving uveitis, lowering serum alkaline phosphatase, and reversing hematologic abnormalities. The underlying pathophysiology responsible for the association of these 2 disorders in the same patient remains obscure. However, as more patients are identified, it may be possible to gain a better understanding of the immunologic defect responsible for the dual presentation of these 2 relatively uncommon diseases.
UR - http://www.scopus.com/inward/record.url?scp=10144258655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10144258655&partnerID=8YFLogxK
U2 - 10.1097/00005792-199609000-00002
DO - 10.1097/00005792-199609000-00002
M3 - Article
C2 - 8862347
AN - SCOPUS:10144258655
SN - 0025-7974
VL - 75
SP - 251
EP - 261
JO - Medicine
JF - Medicine
IS - 5
ER -